Association of preoperative CT-derived visceral adipose tissue index with synchronous metastasis and metastasis-free survival after curative-intent surgery in colorectal cancer - Top-Institutions - MDSpire

Association of preoperative CT-derived visceral adipose tissue index with synchronous metastasis and metastasis-free survival after curative-intent surgery in colorectal cancer

  • By

  • Ke Yin

  • Yuchen Xie

  • Qingling Li

  • Guanyi Liao

  • Song He

  • Jinjun Guo

  • June 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Surgical Oncology
    • Colorectal Surgery

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Surgical Oncology
    • Colorectal Surgery

  • #3

    Hacettepe University Oncology Hospital
    Hacettepe University Oncology Hospital

    Ankara, Turkiye

    Key Differentiators

    • Oncology
    • Surgical Oncology

  • #4

    Tongji Hospital
    Tongji Hospital

    Wuhan, Hubei

    Key Differentiators

    • Gastrointestinal Surgery
    • Surgical Oncology

  • #5

    Nanjing Drum Tower Hospital
    Nanjing Drum Tower Hospital

    Nanjing, Jiangsu

    Key Differentiators

    • Surgical Oncology
    • Gastrointestinal Surgery

Original Source(s)

Association of preoperative CT-derived visceral adipose tissue index with synchronous metastasis and metastasis-free survival after curative-intent surgery in colorectal cancer

  • by Ke Yin, Yuchen Xie, Qingling Li, Guanyi Liao, Song He, Jinjun Guo

  • June 2, 2026

Related Content

Comparative analysis of anal sphincter-preserving surgical techniques in ultra-low rectal cancer

Cytokine and chemokine networks in colorectal cancer

Integrated perspectives on colorectal carcinogenesis: molecular pathogenesis, genomic alterations, diagnostic paradigms, therapeutic interventions and AI–driven directions in precision oncology